Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 7Sarcoma 1

Conditions

Dermatofibrosarcoma 2Skin Neoplasms 1Neoplasms, Adnexal and Skin Appendage 1Melanoma 1Histiocytoma, Malignant Fibrous 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 2Specimen Handling 2Nivolumab 2Magnetic Resonance Spectroscopy 2tocilizumab 1poly ICLC 1flt3 ligand protein 1daromun 1SUB1 protein, human 1Radiotherapy 1Radiation 1Mohs Surgery 1Melphalan 1Ipilimumab 1IPI-926 1Capecitabine 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Basal Cell × Mohs Surgery × Sarcoma × Clear all
NCT02310503 2020-05-05

REGESMOHS

Fundación Academia Española de Dermatología

Completed
6,000 enrolled
DermatologicSarcoma

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Melanoma, Skin Neoplasms, Dermatofibrosarcoma, Neoplasms, Adnexal and Skin Appendage, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡